ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,474,343, issued on Nov. 18, was assigned to Progastrine et Cancers S.A R.L. (Luxembourg).

"Compositions and methods for detecting and treating gastric cancer" was invented by Alexandre Prieur (Montpellier, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to methods for the in vitro diagnosis of gastric cancer, and to compositions and methods for the prevention or the treatment of gastric cancer. Disclosed are compositions that include an antibody binding to progastrin and disclosed are methods that include the use of an antibody binding to progastrin."

The patent was filed on Jan. 2, 2017, under Application No. 16/067...